Skip to main content

Propecia Side Effects

Generic name: finasteride

Medically reviewed by Drugs.com. Last updated on Feb 19, 2024.

Note: This document provides detailed information about Propecia Side Effects associated with finasteride. Some dosage forms listed on this page may not apply specifically to the brand name Propecia.

Applies to finasteride: oral tablet.

Serious side effects of Propecia

Along with its needed effects, finasteride (the active ingredient contained in Propecia) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking finasteride:

More common

  • chills
  • cold sweats
  • confusion
  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position

Less common

  • bloating or swelling of the face, arms, hands, lower legs, or feet
  • breast enlargement and tenderness
  • hives or welts, itching, skin rash
  • rapid weight gain
  • redness of the skin
  • swelling of the lips and face
  • tingling of the hands or feet
  • unusual weight gain or loss

Incidence not known

  • clear or bloody discharge from the nipple
  • dimpling of the breast skin
  • inverted nipple
  • lump in the breast or under the arm
  • persistent crusting or scaling of the nipple
  • redness or swelling of the breast
  • sore on the skin of the breast that does not heal

Other side effects of Propecia

Some side effects of finasteride may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • decreased interest in sexual intercourse
  • inability to have or keep an erection
  • loss in sexual ability, desire, drive, or performance

Less common

  • runny or stuffy nose
  • sleepiness or unusual drowsiness
  • sneezing

Less common or rare

Incidence not known

  • testicular pain

For healthcare professionals

Applies to finasteride: oral tablet.

Genitourinary

Most men were older and were taking concomitant medications and/or had comorbid conditions:

Two hundred fourteen reports of gynecomastia in men taking finasteride in the United States were received by the FDA between June 1992 and February 1995. Among those reported, fifty eight percent were taking additional medications that have been associated with gynecomastia. Sixty nine of 86 patients who discontinued finasteride treatment had partial or complete remission.

New reports of drug-related sexual adverse experiences have been reported to decrease with duration of therapy.

Erectile dysfunction has been reported to continue beyond treatment discontinuation. Normalization or improvement of seminal quality has been reported after withdrawing finasteride treatment.[Ref]

Endocrine

Finasteride may cause a decrease in PSA levels in patients with benign prostatic hyperplasia as well as in patients with prostate cancer. In one study, mean PSA reductions of 50% were noted, regardless of baseline levels. There was no indication that PSA levels were further suppressed in patients with prostate cancer.

PSA levels are commonly used in the screening process for prostate cancer. Patients who develop sustained increases in PSA while on finasteride therapy should be carefully evaluated for medical causes as well as noncompliance.[Ref]

Nervous system

Cardiovascular

Oncologic

Gastrointestinal

Dermatologic

A 58 year old man presented with an itchy, lumpy rash on upper and lower extremities following two weeks of finasteride treatment for prostatism. The patient had no known allergies and was taking no other medications prior to the episode. The finasteride was discontinued and dapsone was initiated. The rash resolved two weeks after finasteride therapy was stopped.[Ref]

Hypersensitivity

Metabolic

Respiratory

Psychiatric

Musculoskeletal

Hepatic

References

1. Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS, et al. (1992) "The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group." N Engl J Med, 327, p. 1185-91

2. Steiner JF (1993) "Finasteride: a 5 alpha-reductase inhibitor." Clin Pharm, 12, p. 15-23

3. (2002) "Product Information. Proscar (finasteride)." Merck & Co., Inc

4. Tammela TL, Kontturi MJ (1993) "Urodynamic effects of finasteride in the treatment of bladder outlet obstruction due to benign prostatic hyperplasia." J Urol, 149, p. 342-4

5. Guess HA, Heyse JF, Gormley GJ (1993) "The effect of finasteride on prostate-specific antigen in men with benign prostatic hyperplasia." Prostate, 22, p. 31-7

6. Stoner E, Round E, Ferguson D, Gormley GJ (1994) "Clinical experience of the detection of prostate cancer in patients with benign prostatic hyperplasia treated with finasteride." J Urol, 151, p. 1296-300

7. Volpi R, Maccarini PA, Boni S, Chiodera P, Coiro V (1995) "Finasteride-induced gynecomastia in a 62-year-old man." Am J Med Sci, 309, p. 322-5

8. Guess HA, Gormley GJ, Stoner E, Oesterling JE (1996) "The effect of finasteride on prostate specific antigen: review of available data." J Urol, 155, p. 3-9

9. Stoner E (1996) "5 alpha-reductase inhibitors/finasteride." Prostate, Suppl 6, p. 82-7

10. Green L, Wysowski DK, Fourcroy JL (1996) "Gynecomastia and breast cancer during finasteride therapy." N Engl J Med, 335, p. 823

11. Ferrando J, Grimalt R, Alsina M, Bulla F, Manasievska E (2002) "Unilateral Gynecomastia Induced by Treatment With 1 mg of Oral Finasteride." Arch Dermatol, 138, p. 543-4

12. Thompson IM, Goodman PJ, Tangen CM, et al. (2003) "The influence of finasteride on the development of prostate cancer." N Engl J Med, 349, p. 215-24

13. Australian Government. Department of Health. Therapeutic Goods Administration (2013) Medicines Safety Update, Volume 4, Number 6, December 2013. http://www.tga.gov.au/hp/msu-2013-06.htm

14. Lear JT, Byrne JPH (1996) "Finasteride-related cutaneous vaculitis." Postgrad Med J, 72, p. 127

15. Oyama N, Kaneko F (2009) "Solitary fixed drug eruption caused by finasteride." J Am Acad Dermatol, 60, p. 168-9

Frequently asked questions

Further information

Propecia side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.